Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 21, 2025 11:54AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM Innovent Biologics partners with Takeda in $11.4 billion cancer drug deal
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
Jul 30, 2025 02:41AM
Jul 21, 2025 08:01AM
Jul 21, 2025 08:00AM
Jul 14, 2025 05:55AM
Jul 14, 2025 03:00AM
Jun 30, 2025 08:00AM
Jun 3, 2025 10:13AM Takeda (TAK) announces EC approval of ADCETRIS
Jun 3, 2025 10:12AM
Jun 1, 2025 08:00AM
May 21, 2025 09:32AM
May 14, 2025 05:10PM
May 14, 2025 05:03PM
May 5, 2025 08:00AM
Mar 3, 2025 06:46AM Protagonist Therapeutics (PTGX) and Takeda (TAK) Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Mar 3, 2025 06:45AM
Dec 3, 2024 07:00AM
Nov 7, 2024 07:00AM
Sep 24, 2024 03:00AM
Sep 19, 2024 08:00AM
Aug 7, 2024 06:45AM
Aug 7, 2024 06:45AM Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (
Aug 6, 2024 04:01PM
Jun 22, 2024 10:30PM
Jun 21, 2024 04:00PM
Jun 21, 2024 04:00PM
Jun 18, 2024 08:02AM
Jun 18, 2024 08:00AM
Jun 14, 2024 08:00AM Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
Jun 3, 2024 06:46AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All